Lawrence H. Einhorn - Concepedia

Author

Lawrence H. Einhorn

Indiana University – Purdue University Indianapolis ORCID

Also Known As

Alexander Jones, D T Sleijfer, Einhorn, Lawrence H., Jalal, Shadia I., L Einhorn, L H Einhorn, L. Einhorn, L. H. Einhorn, L. H. Einhorn M.D., L.H. Einhorn

819

Publications

40.6K

Citations

105

H-Index

190

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Palmetto Hematology Oncology Indiana University Health University Medical Center

About

Lawrence H. Einhorn is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	68	174	16K
2	Health Sciences	18	25	1.9K
3	Nursing	5	5	303
4	Arts	2	2	59
5	Engineering	1	1	16

Lawrence H. Einhorn

339

Publications

36.3K

Citations

102

H-Index

Page 1

	Year	Citations
<i>Cis</i>-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer Lawrence H. Einhorn, John P. Donohue Annals of Internal Medicine	1977	1.6K
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide Stephen D. Williams, Robert Birch, Lawrence H. Einhorn, New England Journal of Medicine Cancer ResearchDisseminated Germ-cell TumorsSurgical OncologyMalignant DiseaseMedicine	1987	1.2K
Recommendations on the Use of <sup>18</sup>F-FDG PET in Oncology James Fletcher, Benjamin Djulbegović, Heloisa P. Soares, Journal of Nuclear Medicine	2008	1.1K
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson, Journal of Clinical Oncology	1992	984
Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma Paul B. Chapman, Lawrence H. Einhorn, Michael L. Meyers, Journal of Clinical Oncology	1999	758
Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer Nasser H. Hanna, Paul A. Bunn, Corey J. Langer, Journal of Clinical Oncology	2006	673
Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing Janice Gabrilove, Charles S. Cleeland, Robert B. Livingston, Journal of Clinical Oncology	2001	596
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients Fausto Roila, Alex Molassiotis, Jørn Herrstedt, Annals of Oncology Radiation MedicineRadiation TherapyGastrointestinal OncologyMedicineAdvanced Cancer Patients	2016	569
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. Bruce J. Roth, David H. Johnson, Lawrence H. Einhorn, Journal of Clinical Oncology	1992	548
Treatment of testicular cancer: a new and improved model. Lawrence H. Einhorn Journal of Clinical Oncology Tumor BiologyUrologyAndrologySurgical OncologyInitial Cisplatin	1990	512

Page 1